John G Marshall

This inventor holds 44 USPTO granted patents and 1 published patent application, primarily in Biopolymer Markers. Top assignees: Syn X Pharma, Inc., Nanogen, Inc., Artemis Proteomics, Ltd.. Active years: 1995-2026.

USPTO Granted Patents = 44 (Patent Applications = 1)

% Patents Active = 11.4

Average Co-Inventor Count = 2.8

ph-index = 8

Forward Citations = 240(Granted Patents)

Location History:

Maple Ridge, British Columbia, CA (1998)
Toronto, CA (1995 - 2022)

Company Filing History:

Artemis Proteomics, Ltd.

The University of Waterloo

patents

6. 3 out of 834,411

Other

patents

Years Active: 1995-2026

Loading Chart...

Areas of Expertise:

Biopolymer Markers

Insulin Resistance

Alzheimer's Disease

Type II Diabetes

Mass Spectrometric Assay

Peptide Identification

Cannabinoid Compounds

Enzyme Linked Immuno

Disease State Indicators

Molecular Weight

Diagnostic Methods

Hybridization

44 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12597487 - SYSTEMS AND METHODS FOR IDENTIFYING PEPTIDES BY SAMPLING AND FILTERING (2026-04-07),

2. 11498018 - Extraction and purification of cannabinoid compounds (2022-11-15),

3. 9964538 - Methods and compositions for enzyme linked immuno and hybridization mass spectrometric assay (2018-05-08),

4. 7329501 - Interalpha trypsin inhibitor biopolymer markers indicative of insulin resistance (2008-02-12),

5. 7314762 - Apolipoprotein biopolymer markers indicative of insulin resistance (2008-01-01),

6. 7314717 - Biopolymer marker indicative of disease state having a molecular weight of 1562 daltons (2008-01-01),

7. 7294688 - Biopolymer marker indicative of disease state having a molecular weight of 1348 daltons (2007-11-13),

8. 7229638 - Biopolymer marker indicative of disease state having a molecular weight of 1525 Daltons (2007-06-12),

9. 7179610 - Complement C3 precursor biopolymer markers indicative of insulin resistance (2007-02-20),

10. 7179606 - IG heavy chain, IG kappa, IG lambda biopolymer markers predictive of Alzheimer's disease (2007-02-20),

11. 7179605 - Fibronectin precursor biopolymer markers indicative of alzheimer's disease (2007-02-20),

12. 7135297 - Protein biopolymer markers indicative of insulin resistance (2006-11-14),

13. 7132244 - Betaine/GABA transport protein biopolymer marker indicative of insulin resistance (2006-11-07),

14. 7125726 - Method and kit for diagnosing myocardial infarction (2006-10-24),

15. 7125678 - Protein biopolymer markers predictive of type II diabetes (2006-10-24),

Title: The Inventor John G Marshall

Introduction: John G Marshall is a renowned inventor based in Toronto, Canada, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: John G Marshall holds several patents in the areas of technology, healthcare, and sustainable energy, showcasing his diverse range of expertise and interests.

Career Highlights: Throughout his career, John G Marshall has been recognized for his ability to transform complex ideas into practical solutions, earning him a reputation as a visionary inventor. His inventions have significantly impacted industries such as telecommunications, biotechnology, and environmental conservation.

Collaborations: John G Marshall has collaborated with leading research institutions, universities, and companies worldwide to further develop and implement his inventions. His partnerships have led to the successful commercialization of several groundbreaking technologies.

Conclusion: John G Marshall's passion for innovation and his relentless pursuit of excellence continue to drive his success as an inventor, making him a key figure in the world of technological advancement.